Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.72
+0.07 (0.45%)
At close: Nov 13, 2026, 4:00 PM EST
15.78
+0.06 (0.40%)
After-hours: Nov 13, 2026, 7:30 PM EST
Rallybio Market Cap
Rallybio has a market cap or net worth of $84.64 million as of November 13, 2026. It is the 26,116th most valuable company in the world and the 4,182nd biggest in the United States. Its market cap has increased by 186.95% in one year.
Market Cap
84.64M
Enterprise Value
-6.06M
1-Year Change
186.95%
Global Rank
Country Rank
#4,182 United States
Category
ChartMarket Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $84.64M, a decrease of -79.13%. That is a compound annual growth rate of -25.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 84.64M | 192.01% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 90.60M |
| Coherus Oncology | 90.02M |
| Neumora Therapeutics | 88.87M |
| Cibus | 88.66M |
| Seer, Inc. | 88.04M |
| Tenaya Therapeutics | 84.61M |
| Genelux | 84.25M |
| Atara Biotherapeutics | 82.61M |